Answers are grounded in this paper and cite their sources.
SUMMARYHIV continues to be a worldwide health concern despite great progress made in antiretroviral therapy (ART). This provokes the search for new therapeutic and cure strategies. Protein kinase C (PKC) agonists have emerged as promising candidates for HIV cure research due to their ability to reactivate latent HIV reservoirs and potentially promote their clearance. This review discusses the current knowledge on mechanisms of action of PKC agonists, their impact on HIV reservoirs, and their possible integration into a functional cure strategy. We also discussed the difficulties and potential paths forward in the use of PKC agonists for HIV treatment or functional cure. Overall, PKC agonists offer a promising and compelling direction for HIV cure research and demand additional research.
No takes yet. Share an insight, caveat, or question.
Atanniba et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: